| -
The Foundation periodically awards the Echevarne Foundation National
Oncology Prize, with the aim of rewarding and encouraging research
work, both basic and applied, which leads to advances and provides
new perspectives to the problem of cancer.
The prize is open to any research work carried out by research staff
at all Spanish centres, both public and private, in the framework
of topics related to basic aspects and molecular pathology of cancer.
-The development and/or introduction of techniques or detection
systems for genetic abnormalities involved in the carcinogenic process
-The identification and/or prognostic evaluation of tumour markers
or the research on other genotypic or phenotypic aspect of such
markers -Other advances in the field of development or implementation
of new cancer therapies -Any other research work related to the
basic mechanisms of neoplastic transformation with direct foreseable
impact in the cancer clinic or in any of the above points
To evaluate all these studies, the Foundation relies on the cooperation
of a Scientific Committee made up of professionals of recognised
international prestige: Dr. Carlos Cordón-Cardo, Dr. Joan
Massagué, Dr. Angel Pellicer and Dr. Manuel Perucho.
| 1995
- I Echevarne Foundation National Oncology Prize |
 |
- In 1995 the first Echevarne Foundation National Oncology Prize was held.
The winner was Dr. Carlos López-Otín for his work on the
Structural and Functional Identification and Characterisation of new Proteolytic
Enzymes and inhibtors of Proteases associated with Mammarian Carcinoma.
Carlos López-Otín graduated and obtained his PhD at the
Complutense University of Madrid. His work was the result of several years
of investigation on the molecular processes governing breast cancer cell
dissemination. Since 1993 he has been Professor of Biochemistry and Molecular
Biology in the Medical Faculty of the University of Oviedo.
| 1999
- II Echevarne Foundation National Oncology Prize |
 |
-
The Second National Prize was held in 1999. It was won by Dr. María
A. Blasco for her work on The Implication of Telomerase and Telomeres
in Chromosomic Instability and Cancer.
María Blasco graduated and obtained her PhD at the Autonomous University
of Madrid. She initiated her studies on the activity of the enzyme Telomerase
and its implication in cancer during her Post-Doctoral stay at the Cold
Spring Harbor Laboratory in New York (1993-1996). Nowadys, she leads the Oncology Molecular Program, in the CINIO on Madrid.
The study and identification of the genes implicated in these telomeric
maintenance mechanisms is fundamental in order to understand the progession
of tumours.
|